Nombre del producto:tert-butyl 4-(4-bromophenyl)-4-hydroxypiperidine-1-carboxylate

IUPAC Name:tert-butyl 4-(4-bromophenyl)-4-hydroxypiperidine-1-carboxylate

CAS:163209-96-9
Fórmula molecular:C16H22BrNO3
Pureza:95%+
Número de catálogo:CM127634
Peso molecular:356.26

Unidad de embalaje Stock disponible Precio($) Cantidad
CM127634-25g in stock Ŕƞșƻ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :163209-96-9
Fórmula molecular:C16H22BrNO3
Punto de fusión:-
Código de sonrisas:O=C(N1CCC(O)(C2=CC=C(Br)C=C2)CC1)OC(C)(C)C
Densidad:
Número de catálogo:CM127634
Peso molecular:356.26
Punto de ebullición:438.1°C at 760 mmHg
Nº Mdl:MFCD08689589
Almacenamiento:Store at 2-8°C.

Category Infos

Piperidines
Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
Piperidine,Piperidine Price
if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.
Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Denifanstat
Sagimet Biosciences announced positive topline results from its FASCINATE-2 Phase 2b clinical trial of denifanstat versus placebo in biopsy-confirmed non-alcoholic steatohepatitis (NASH) patients with stage 2 or stage 3 fibrosis (F2/F3) at week 52. Denifanstat, an oral, selective FASN inhibitor, achieved statistically significant results on primary and multiple secondary endpoints.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.